The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.

The study, published in The Lancet Haematology, has revealed that the injection had a 73% response rate among Indian patients ...

Bexobrutideg, a first-in-class Bruton’s tyrosine kinase degrader, has been granted orphan drug designation from the FDA in ...

A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Apart from breathing issues like breathlessness and pain in the chest, signs and symptoms of lung cancer extend way beyond, ...

BioVaxys common shares are listed on the Canadian Securities Exchange under the stock symbol "BIOV" and trade on the Frankfurt Bourse (FRA: 5LB) and in the U.S. on the OTC Markets (OTCQB marketplace).

The Work and Pensions Secretary has announced plans to tighten the eligibility criteria for Personal Independence Payment ...

Napa photographer Bob McClenahan captured evocative images of Napa Valley, people, places and happenings. He died on March 7 ...

This therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and significantly reducing costs, thus enhancing accessibility in India and ...

Equities research analysts at Roth Capital issued their FY2029 earnings per share estimates for Cellectar Biosciences in a ...